Jean‐François Seitz

机构：Hôpital de la Timone

发表论文 228 篇 · 总被引 16950 次 · h-index 53

代表论文

• Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial (2021 · The Lancet Oncology · 被引 1365)
• Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial (2017 · The Lancet Oncology · 被引 842)
• Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19) (2020 · European Journal of Cancer · 被引 168)
• Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study (2018 · The Oncologist · 被引 145)
• Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma (2019 · Journal of Hepatology · 被引 117)
• Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer (2017 · Annals of Oncology · 被引 108)